Rye is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Rye.
Product ID | 49288-0442_1d11d7ba-8b48-401c-a02e-42b54abb4296 |
NDC | 49288-0442 |
Product Type | Human Prescription Drug |
Proprietary Name | Rye |
Generic Name | Rye |
Dosage Form | Injection, Solution |
Route of Administration | INTRADERMAL; SUBCUTANEOUS |
Marketing Start Date | 1974-03-23 |
Marketing Category | BLA / BLA |
Application Number | BLA102223 |
Labeler Name | Antigen Laboratories, Inc. |
Substance Name | RYE |
Active Ingredient Strength | 0 g/mL |
Pharm Classes | Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Grain Proteins [EXT] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 1974-03-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Ingredient | Strength |
---|---|
RYE | .05 g/mL |
NDC | Brand Name | Generic Name |
---|---|---|
49288-0442 | Rye | Rye |
54575-453 | RYE FOOD | rye |
0268-6210 | RYE GRAIN | RYE |